TACE as an Adjuvant Therapy After Hepatectomy for HCC

Summary

Investigators hypothesise that the use of transarterial chemoembolisation (TACE) after liver resection in patients with hepatocellular carcinoma can eradicate residual cancer cells in the liver and thus improve survival of patients with high risk factors for residual tumor. The aim of this study is to compare the survival of patients with high risk factors for residual tumor undergoing liver resection plus post-operative TACE versus liver resection alone.

Timeline

Start

2011-08

Primary completion

2016-08

Completion

2017-08

Drugs

Indications